Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER_GOV × Esophagitis × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

OTHER 3 INDUSTRY 2 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Breast Neoplasms 52 Carcinoma, Non-Small-Cell Lung 31 Stomach Neoplasms 27 Colorectal Neoplasms 22 Small Cell Lung Carcinoma 18 Lung Neoplasms 18 Rectal Neoplasms 15 Neoplasm Metastasis 14 Pancreatic Neoplasms 12 Neoplasms 12 Esophageal Neoplasms 12 Ovarian Neoplasms 11 Nasopharyngeal Carcinoma 11 Uterine Cervical Neoplasms 10 Recurrence 9 Leukemia, Myeloid, Acute 9 Carcinoma, Hepatocellular 9 Melanoma 8 Lymphoma, Non-Hodgkin 7 Head and Neck Neoplasms 7 Esophageal Squamous Cell Carcinoma 7 Colonic Neoplasms 7 Triple Negative Breast Neoplasms 6 Hodgkin Disease 6 Squamous Cell Carcinoma of Head and Neck 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasms, Germ Cell and Embryonal 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma 5 Cholangiocarcinoma 5

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation

Breast Neoplasms, Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡